Preferred Name |
Umeclidinium Bromide |
|
Synonyms |
GSK 573719A GSK-573719A Umeclidinium Bromide UMECLIDINIUM BROMIDE GSK573719A Incruse |
|
Definitions |
The bromide salt form of umeclidinium, a muscarinic receptor antagonist, with bronchodilator activity. Although it does not display selectivity for specific muscarinic receptors, on topical application, umeclidinium acts mainly on M3 muscarinic receptors located on smooth muscle cells, thereby preventing smooth muscle contraction and resulting in bronchodilatory effect. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C152797 |
|
CAS_Registry |
869113-09-7 |
|
code |
C152797 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
The bromide salt form of umeclidinium, a muscarinic receptor antagonist, with bronchodilator activity. Although it does not display selectivity for specific muscarinic receptors, on topical application, umeclidinium acts mainly on M3 muscarinic receptors located on smooth muscle cells, thereby preventing smooth muscle contraction and resulting in bronchodilatory effect. |
|
FDA_UNII_Code |
7AN603V4JV |
|
FULL_SYN |
GSK 573719A GSK-573719A Umeclidinium Bromide UMECLIDINIUM BROMIDE GSK573719A Incruse |
|
label |
Umeclidinium Bromide |
|
NCI_Drug_Dictionary_ID |
804497 |
|
PDQ_Closed_Trial_Search_ID |
804497 |
|
PDQ_Open_Trial_Search_ID |
804497 |
|
Preferred_Name |
Umeclidinium Bromide |
|
prefixIRI |
Thesaurus:C152797 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C3709474 |
|
subClassOf |